BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33743793)

  • 1. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
    Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
    Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessibility, availability and common practices regarding genetic testing for epilepsy across Europe: A survey of the European Reference Network EpiCARE.
    Papadopoulou MT; Muccioli L; Bisulli F; Klotz KA; Fons C; Trivisano M; Kabulashvili T; Specchio N; Lesca G; Arzimanoglou A
    Epilepsia Open; 2024 Jun; 9(3):996-1006. PubMed ID: 38517305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.
    Bernts LHP; Jones DEJ; Kaatee MM; Lohse AW; Schramm C; Sturm E; Drenth JPH
    Orphanet J Rare Dis; 2019 Jul; 14(1):169. PubMed ID: 31287000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).
    Nanetti L; Kearney M; Boesch S; Stovickova L; Ortigoza-Escobar JD; Macaya A; Gomez-Andres D; Roze E; Molnar MJ; Wolf NI; Darling A; Vasco G; Bertini E; Indelicato E; Neubauer D; Haack TB; Sagi JC; Danti FR; Sival D; Zanni G; Kolk A; Boespflug-Tanguy O; Schols L; van de Warrenburg B; Vidailhet M; Willemsen MA; Buizer AI; Orzes E; Ripp S; Reinhard C; Moroni I; Mariotti C;
    Neurol Sci; 2024 Mar; 45(3):1007-1016. PubMed ID: 37853291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network - EVICR.net.
    Lorenz B; Tavares J; van den Born LI; Marques JP; Pilotto E; Stingl K; Charbel Issa P; Leroux D; Dollfus H; Scholl HPN; ;
    Ophthalmic Res; 2023; 66(1):550-568. PubMed ID: 36592621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN).
    Eggermann T; Elbracht M; Kurth I; Juul A; Johannsen TH; Netchine I; Mastorakos G; Johannsson G; Musholt TJ; Zenker M; Prawitt D; Pereira AM; Hiort O;
    Orphanet J Rare Dis; 2020 Jun; 15(1):144. PubMed ID: 32513286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases.
    Zurek B; Ellwanger K; Vissers LELM; Schüle R; Synofzik M; Töpf A; de Voer RM; Laurie S; Matalonga L; Gilissen C; Ossowski S; 't Hoen PAC; Vitobello A; Schulze-Hentrich JM; Riess O; Brunner HG; Brookes AJ; Rath A; Bonne G; Gumus G; Verloes A; Hoogerbrugge N; Evangelista T; Harmuth T; Swertz M; Spalding D; Hoischen A; Beltran S; Graessner H;
    Eur J Hum Genet; 2021 Sep; 29(9):1325-1331. PubMed ID: 34075208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
    Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
    Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
    Vos JR; Giepmans L; Röhl C; Geverink N; Hoogerbrugge N;
    Fam Cancer; 2019 Apr; 18(2):281-284. PubMed ID: 30302652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genomic landscape of rare disorders in the Middle East.
    El Naofal M; Ramaswamy S; Alsarhan A; Nugud A; Sarfraz F; Janbaz H; Taylor A; Jain R; Halabi N; Yaslam S; Alfalasi R; Shenbagam S; Rabea F; Bitzan M; Yavuz L; Wafadari D; Abulhoul H; Shankar S; Al Maazmi M; Rizk R; Alloub Z; Elbashir H; Babiker MOE; Chencheri N; AlBanna A; Sultan M; El Bitar M; Kherani S; Thalange N; Alshryda S; Di Donato R; Tzivinikos C; Majid I; Freeman AF; Gonzalez C; Khan AO; Hamdan H; Abuhammour W; AlAwadhi M; AlKhayat A; Alsheikh-Ali A; Abou Tayoun AN
    Genome Med; 2023 Jan; 15(1):5. PubMed ID: 36703223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Understanding of Inequities in Rare Disease Genomics.
    Serrano JG; O'Leary M; VanNoy GE; Mangilog BE; Holm IA; Fraiman YS; Rehm HL; O'Donnell-Luria A; Wojcik MH
    Clin Ther; 2023 Aug; 45(8):745-753. PubMed ID: 37517917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges raised by cross-border testing of rare diseases in the European union.
    Pohjola P; Hedley V; Bushby K; Kääriäinen H
    Eur J Hum Genet; 2016 Nov; 24(11):1547-1552. PubMed ID: 27381091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of genomic sequencing.
    Neu MB; Bowling KM; Cooper GM
    Curr Opin Pediatr; 2019 Dec; 31(6):732-738. PubMed ID: 31693580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).
    Pinto E Vairo F; Kemppainen JL; Vitek CRR; Whalen DA; Kolbert KJ; Sikkink KJ; Kroc SA; Kruisselbrink T; Shupe GF; Knudson AK; Burke EM; Loftus EC; Bandel LA; Prochnow CA; Mulvihill LA; Thomas B; Gable DM; Graddy CB; Garzon GGM; Ekpoh IU; Porquera EMC; Fervenza FC; Hogan MC; El Ters M; Warrington KJ; Davis JM; Koster MJ; Orandi AB; Basiaga ML; Vella A; Kumar S; Creo AL; Lteif AN; Pittock ST; Tebben PJ; Abate EG; Joshi AY; Ristagno EH; Patnaik MS; Schimmenti LA; Dhamija R; Sabrowsky SM; Wierenga KJ; Keddis MT; Samadder NJJ; Presutti RJ; Robinson SI; Stephens MC; Roberts LR; Faubion WA; Driscoll SW; Wong-Kisiel LC; Selcen D; Flanagan EP; Ramanan VK; Jackson LM; Mauermann ML; Ortega VE; Anderson SA; Aoudia SL; Klee EW; McAllister TM; Lazaridis KN
    J Transl Med; 2023 Jun; 21(1):410. PubMed ID: 37353797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study.
    Peterlin B; Gualandi F; Maver A; Servidei S; van der Maarel SM; Lamy F; Mejat A; Evangelista T; Ferlini A
    PLoS One; 2020; 15(9):e0239329. PubMed ID: 32946487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
    Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
    Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Answers for Kids: Toward more equitable access to genomic testing for rare diseases in rural populations.
    Cohen ASA; Berrios CD; Zion TN; Barrett CM; Moore R; Boillat E; Belden B; Farrow EG; Thiffault I; Zuccarelli BD; Pastinen T
    Am J Hum Genet; 2024 May; 111(5):825-832. PubMed ID: 38636509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance in ERN eUROGEN for penile, testicular, adrenal and soft tissue cancers.
    Ashley S; Shilhan D; Battye M; Meyer C; Mancini M; Ayres B; Muneer A; Albersen M; Feitz W; Langenhuijsen JF; Sangar V
    Eur J Surg Oncol; 2022 Mar; 48(3):680-686. PubMed ID: 34893364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.